Psychopharmacology and ethnicity
An evidence-based database
Important interethnic differences in response to psychotropic drugs are reported in numerous scientific studies. This site aims to assemble these differences.
Scientific knowledge about psychopharmacology is mainly based on scientific research among western/white/caucasian populations. We hope that this site will offer clinicians an important tool in improving their psychopharmacological treatment in ethic diverse patients.
This site focusses only on the, sometimes large, ethnic variations in psychopharmacology and offers evidende based data to aid clinicians in personalizing the treatment of their patients.
It is important to keep in mind that drugs response is not solely influenced by ethnicity but many other variables. Ethnic differences are often superimposed on substantial interindividual variation within each ethnic group.
This website is intended for psychiatrists and other medical doctors and not intended to serve as medical advice for patients nor a substitute for a doctor’s appointment.
The information on this site should not be used by patients for treating a disease or changing their medication themselves. At all times medical advice should be obtained by professional doctors.
World map: interethnic differences in population prevalence of the HAL-B*1502 allele
World map: interethnic differences in drug metabolism: CYP2D6
World map: interethnic differences in drug metabolism: CYP2C9 (coming soon)
World map: interethnic differences in drug metabolism: CYP2C19 (coming soon)
World map: interethnic differences in drug metabolism: CYP3A5 (coming soon)
World map: CYP2D6 Non-Normal Metabolizer Risk Score
World map: CYP2C19 Non-Normal Metabolizer Risk Score